Variation in NCB5OR
Studies of Relationships to Type 2 Diabetes, Maturity-Onset Diabetes of the Young, and Gestational Diabetes Mellitus
- Gitte Andersen1,
- Lise Wegner1,
- Christian Schack Rose1,
- Jianxin Xie2,
- Hao Zhu2,
- Kevin Larade2,
- Anders Johansen1,
- Jakob Ek1,
- Jeannet Lauenborg3,
- Thomas Drivsholm4,
- Knut Borch-Johnsen14,
- Peter Damm3,
- Torben Hansen1,
- H. Franklin Bunn2 and
- Oluf Pedersen15
- 1Steno Diabetes Center, Gentofte, Denmark
- 2Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
- 3Obstetric Clinic, National University Hospital, Rigshospitalet, Copenhagen, Denmark
- 4Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark
- 5Faculty of Health Science, Aarhus University, Aarhus, Denmark
- Address correspondence and reprint requests to Gitte Andersen, MSc, Steno Diabetes Center and Hagedorn Research Institute, Niels Steensens Vej 2, NSH2.16, DK-2820 Gentofte, Denmark. E-mail: gtta{at}steno.dk
Abstract
Recent data show that homozygous Ncb5or−/− knock-out mice present with an early-onset nonautoimmune diabetes phenotype. Furthermore, genome-wide scans have reported linkage to the chromosome 6q14.2 region close to the human NCB5OR. We therefore considered NCB5OR to be a biological and positional candidate gene and examined the coding region of NCB5OR in 120 type 2 diabetic patients and 63 patients with maturity-onset diabetes of the young using denaturing high-performance liquid chromatography. We identified a total of 22 novel nucleotide variants. Three variants [IVS5+7del(CT), Gln187Arg, and His223Arg] were genotyped in a case-control design comprising 1,246 subjects (717 type 2 diabetic patients and 529 subjects with normal glucose tolerance). In addition, four rare variants were investigated for cosegregation with diabetes in multiplex type 2 diabetic families. The IVS5+7del(CT) variant was associated with common late-onset type 2 diabetes; however, we failed to relate this variant to any diabetes-related quantitative traits among the 529 control subjects. Thus, variation in the coding region of NCB5OR is not a major contributor in the pathogenesis of nonautoimmune diabetes.
- dHPLC, denaturing high-performance liquid chromatography
- GCK, glucokinase
- GDM, gestational diabetes mellitus
- HNF, hepatocyte nuclear factor
- MAF, minor allele frequency
- MODY, maturity-onset diabetes of the young
- NCBI, National Center for Biotechnology Information
- NGT, normal glucose tolerance
- OGTT, oral glucose tolerance test
- OHA, oral hypoglycemic agent
- RFLP, restriction fragment–length polymorphism
- RG, restriction site generating
- SNP, single nucleotide polymorphism
Footnotes
-
- Accepted July 21, 2004.
- Received June 1, 2004.
- DIABETES














